| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.066 | 0.3 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.3 |